Development of novel monoclonal antibodies against nsp12 of SARS-CoV-2

Retrieved on: 2022-12-10 12:01:05

Tags for this article:

Click the tags to see associated articles and topics

Development of novel monoclonal antibodies against nsp12 of SARS-CoV-2. View article details on hiswai:

Excerpt

Here, we succeeded to develop novel mouse monoclonal antibodies (mAbs) that recognize SARS-CoV-2 nsp12, catalytic subunit of the RdRP.

Article found on: virologyj.biomedcentral.com